News
480 Biomedical starts human trial
Mon, 04/16/2012 - 10:32am
Arsenal Medical spinout 480 Biomedical Inc. of Watertown said it has started the first human trial of a bioresorbable scaffold aimed at treating peripheral artery disease by restoring blood flow to the leg.
